Naveris

About Naveris

Naveris develops highly sensitive blood tests and liquid biopsy technologies for cancer detection and monitoring. Their NavDx product enables surveillance of HPV-related cancers through non-invasive assays, with applications in early cancer detection, treatment response monitoring, and recurrence detection. The company operates in the United States with a focus on clinical diagnostics and translational cancer research.